1. Protein degradation in rat hepatocytes in stationary monolayer culture was measured as release of radioactive trichloroacetic acid-soluble material from intracellular proteins labelled with [3H]leucine. 2. Glucocorticoids, but not other steriods, stimulated protein breakdown in the hepatocyte monolayers. The effects observed were greater when the cells were preincubated with the hormones, indicating that the stimulation was not immediate. In addition, the stimulation by glucocorticoids persiste4 for up to 4h after hormone removal. 3. Cycloheximide and the lysosomotropic agents leupeptin and ammonia effectively blocked glucocorticoid stimulation of protein degradation. 4. Insulin blocked dexamethasone stimulation when added at the same time as the steroid, but not when added 3 h later. 5. Stimulation of protein breakdown by dexamethasone was additive with that by glucagon or dibutyryl cyclic AMP, suggesting that its mechanism of action is different from that of the latter two agents. 6. Total activities of several lysosomal enzymes were unaffected under conditions where protein breakdown was stimulated by either glucagon or dexamethasone. 7. It is suggested that, whereas glucagon, dibutyryl cyclic AMP and insulin modulate protein breakdown in these cells via changes in autophagocytosis, the stimulation by glucocorticoids is exerted independently, perhaps by stimulating the synthesis of membrane proteins essential to the autophagic process.
Glucocorticoid administration in vivo leads to protein catabolic effects in muscle and other peripheral tissues. Muscle protein synthesis is decreased (Wool & Weinshelbaum, 1960; Young, 1970; Hanoune et al., 1972) and muscle protein breakdown is increased (Goldberg, 1969 (Goldberg, , 1975 Tomas et al., 1979) . Even though the amount of liver protein increases soon after glucocorticoid injection (Goodlad & Munro, 1959; Henderson et al., 1971) , the amino acids produced from extra-hepatic tissues are not fully accounted for by protein accumulation in liver. Excess amino acids are utilized in gluconeogenesis leading to increased glycogen synthesis and deposition, and by oxidation, leading to an overall negative nitrogen balance (Steele, 1975) . Measurements of liver protein synthesis and degradation after glucocorticoid administration have yielded conflicting results. Protein synthesis has been reported to be inhibited (Kim & Kim, 1975) , unaffected (Hanoune et al., 1972) or stimulated (Feigelson & Feigelson, 1963; Hanoune & Feigelson, 1970; Millward et al., 1976) , and protein degradation is increased (Chertow et al., 1973) or unaffected (Kim & Kim, 1975 al., 1974) . Dietary differences may also be expected to exert a significant effect on these measurements (Munro, 1964) . In addition, corticosteroids may alter circulating concentrations of other hormones such as insulin (Millward et al., 1976; Tomas et al., 1979) , which directly modulate protein synthesis or degradation (Ballard, 1980) . Finally, problems of measurement of protein synthesis and degradation in vivo are recognized (Goldberg & Dice, 1974; Ballard, 1977; Waterlow et al., 1978) , but are hard to overcome. Some problems can be avoided by using the isolated perfused liver, but difficulties with tissue viability occur over the long period required for measurements of protein degradation. Experiments with hepatoma cells in culture have indicated that protein breakdown is stimulated by glucocorticoids in HTC (Gelehrter & Emanuel, 1974) and H35 (Gunn et al., 1976) (Knowles et al., 1975; Knowles & Ballard, 1976; Hopgood et al., 1977 Hopgood et al., , 1980 . Preparation and culture ofhepatocytes Animals, diet, lighting schedule and the preparation and culture of hepatocytes were as described previously (Hopgood et al., 1980 (Hopgood et al., 1980) in the time period from 6 to 22 h after plating, followed by a 3 h 'chase' period and a 4 h measurement period as described by Hopgood et al. (1980) .
In experiments where cells were preincubated with agents before the measurement period, the appropriate compound was added to the chase medium (3 h preincubation) or to the pulse and the chase media (19 h preincubation). Routine removal of the chase medium, followed by two washes with control medium to remove residual soluble radioactivity from the monolayers, also served to decrease the concentration of the preincubation agent to an insignificant value.
At the end of the degradation period, incubation media were removed and trichloroacetic acid (final concn. 1 M) was added to each sample of medium. After storage at 4°C for 16h, radioactivity in the trichloroacetic acid-soluble and -insoluble fractions was determined. Total radioactivity in the cells was measured after dissolving the monolayers by trituration in 0.5 M-NaOH/0.5% Triton X-100. In preliminary experiments, cell-associated trichloroacetic acid-soluble radioactivity was found to be less than 5% of that in the medium and was not modified by treatments which stimulated or inhibited protein breakdown. Thereafter this fraction was not measured independently, but was included in the total cellular radioactivity recovered in harvesting the cell monolayer. The percentage protein degradation at 4h was calculated as 100 times the radioactivity in the trichloroacetic acid-soluble fraction of the medium divided by the total radioactivity in all fractions. Radioactivity in the trichloroacetic acid-insoluble fraction of the medium, normally less than 6% of the total trichloroacetic acid-insoluble radioactivity, was used as an index of cellular integrity.
Methods of radioactivity determination, statistical treatment of results and protein assay were as described previously (Hopgood et al., 1980) .
Assays oflysosomal enzymes
After removal of the incubation medium, cell monolayers were harvested in 1 ml of 0.5% Triton X-100 and frozen. The thawed samples were homogenized to produce uniform suspensions and assayed for lysosomal enzyme activities and total protein.
Acid phosphatase activity was assayed as described by Bodansky (1972) . N-Acetyl-/J-D-glucosaminidase and J-D-galactosidase were assayed by the methods of Plattner & Henning (1975) . Cathepsin D was assayed by the method of Hille et al. (1970) and activity calculated as ug of [3H]acetyl-haemoglobin hydrolysed/min. Cathepsin B activity was measured with 3H-labelled liver-cell protein as substrate. This material was prepared by incubating monolayers with [3H]-leucine as in the degradation experiments. Subsequently the cells were dissolved in 0.1 M-NaOH, the pH was adjusted to 5.5 with 0.5 M-HCI and the sample was passed through a Sephadex G-100 column pre-equilibrated with 50mM-sodium citrate, pH 5.5. The high-molecular-weight protein fractions eluted first from this column contained approx. 2 x 10 d.p.m./mg of protein and were used without further treatment. Proteolysis was followed as the rate of formation of radioactive material that was soluble in 0.6M-trichloroacetic acid. All incubations contained 1 mM-dithiothreitol and 1 mM-EDTA. Measured rates of proteolysis were corrected for that occurring in the absence of cell homogenate, which was approx. 20% of the rate observed in the presence of the homogenate. Proteinase activity inhibited by leupeptin (50,ug/ml) is referred to as cathepsin B, even though cathepsin L and possibly 1981 some serine proteinases would be similarly inhibited. General proteinase activity at pH 4.0 was also measured, in the absence of EDTA, dithiothreitol and leupeptin, by using the same labelled substrate as used for the cathepsin B assays.
Results and discussion

Effects ofsteroid hormones
Of the steroids examined, only the glucocorticoid group was found to have significant effects on protein breakdown when added to monolayers at the beginning of the measurement period (Table 1) (Spain, 1975) , and consequently its lesser potency is not surprising. Aldosterone possesses weak physiological glucocorticoid activity (Goodman & Gilman, 1970) , consistent with a direct effect on protein degradation.
Other steroids tested but without effect on protein breakdown were oestradiol-1 7,, oestriol, oestrone and testosterone (results not shown). Progesterone was found to inhibit measured protein degradation, When the sensitivity of protein breakdown to glucocortocoids was tested, significant stimulation was found with dexamethasone at 0.1,uM and with cortisol and corticosterone at 1,UM. Maximal effects were observed at 10puM concentration of all three hormones. Protein-degradation rates were less than maximal when glucocorticoids were added at 100puM. Such high steroid concentrations probably caused cell death, since some cells were observed to be lifting from the plates.
Dexamethasone effects in combination with other hormones
We have previously reported that protein breakdown in hepatocyte monolayers is stimulated by glucagon and dibutyryl cyclic AMP and inhibited by insulin (Hopgood et al., 1980) . Consequently we examined the stimulation by dexamethasone in the presence of each of these agents, since the observation of additive effects might indicate different mechanisms of action. Dexamethasone stimulated protein breakdown in the presence of a maximally effective concentration of glucagon (10nM; Hopgood et al., 1980) or dibutyryl cyclic AMP (0.1mM; Hopgood et al., 1980) . The extent of stimulation was similar to that observed when dexamethasone was added alone (Fig. 1) . This result is consistent with the proposition that the stimulation by the glucocorticoid occurs via a different mechanism from that of glucagon, since the latter elevates intracellular cyclic AMP concentrations in parallel with its stimulation of protein degradation (Hopgood et al., 1980) . In the presence of a maximally effective concentration of insulin (10nM; Hopgood et al., 1980) , the stimulation of protein degradation by dexamethasone was not observed (Fig. 1) .
We have also examined the dexamethasone stimulation in the presence of other inhibitors of protein breakdown. Leupeptin, which inhibits lysosomal cathepsin B (Ikezawa et al., 1971) , and ammonia, which raises the intralysosomal pH (Reijngoud et al., 1976) , were both effective inhibitors of protein breakdown in hepatocyte monolayers (Table 2) . Dexamethasone did not stimulate protein breakdown in the presence of these agents ( Table 2 ), suggesting that the pathway of protein degradation increased by glucocorticoids is a lysosomal system. Leupeptin and ammonia also prevent glucagon stimulation of protein degradation in hepatocyte monolayers (Hopgood et al., 1980; Hopgood & Ballard, 1980) . The dexamethasone stimulation of protein breakdown was abolished in the presence of the protein-synthesis inhibitor cycloheximide (Table 2 ). This is evidence that protein synthesis is required for glucocorticoid action, and provides another indication of a fundamental dif- ference between the mechanism of stimulation of protein degradation by glucocorticoids and by glucagon. We have previously shown that glucagon stimulation of protein degradation persisted in the presence of cycloheximide (Hopgood et al., 1980) .
Effect ofpreincubation with dexamethasone
Current concepts of glucocorticoid action are based on evidence of entrance of the steroids into the cell, interaction with specific cytoplasmic receptors and the initiation by the receptor-steroid complexes of intra-and extra-nuclear synthetic events such as DNA synthesis, transcription and translation (Litwack & Singer, 1972; Thompson & Lippman, 1974; Cake & Litwack, 1975) . Action of a steroid by this sequence of reactions might take a significant period of time in relation to the 4 h period over which we measure protein breakdown, and consequently the stimulation observed during an 'acute' 4 h exposure to the hormones may have been less than maximal. Accordingly, monolayers were exposed to 10,uM-dexamethasone for 19 h (during pulse and chase periods) or for 3 h (during chase period only) before the 4 h measurement period. Preliminary results indicated that stimulation of protein breakdown after either of these preincubation periods was double that observed with an acute 4h exposure to the glucocorticoid. Since the stimulation was the same for both periods of preincubation (results not shown), a regime of 3 h preincubation was adopted for subsequent experiments.
In monolayers exposed to dexamethasone for 3 h before and also during the 4h measurement period, protein degradation was stimulated by up to 20% (Fig. 2) . Significant stimulation was evident with 10 nM-dexamethasone and a maximal stimulation was observed at 100nm, much lower concentrations than were effective with acute 4h exposure to the steroid. Similar results were obtained by preincubation of the cells with corticosterone. Protein degradation was significantly stimulated by 0.1pM-corticosterone, and a maximal stimulation of 18% was observed at a concentration of 1,UM (Fig. 2) . In contrast, acute exposure to corticosterone indicated that protein degradation was stimulated no more than 10% by 10-fold higher concentrations of the hormone (Fig. 2) . Since the plasma corticosterone concentration in normal rats is approx. 0.1 ,UM (L'Age et al., 1974; Tomas et al., 1979) , it is evident that changes in plasma corticosteroid concentrations in the normal physiological range might be expected to exert a considerable influence on protein breakdown in hepatic parenchymal cells. Protein degradation in some cell types may, of course, be insensitive to glucocorticoid stimulation, as was reported for rat embryo fibroblasts in culture (Warburton & Poole, 1977) . However, these fibroblasts were exposed to dexamethasone only for the ' 3 r ilk 2 h period over which measurements were conducted, and the lack of response may have been due to insufficient time being allowed for the hormone to act.
The stimulation of protein breakdown by dexamethasone was not observed when cycloheximide was added with the steroid during the preincubation period (Fig. 3) . This confirms that the glucocorticoid effect is dependent on protein syn-12 thesis, as previously indicated for the acute-exposure experiments (see Table 2 ).
When monolayers were preincubated for 3 h with dexamethasone and then incubated in its absence for the 4h measurement period (Table 3 , line 3), the degree of stimulation of protein breakdown was greater than in the 4 h acute effect and similar to the response observed when dexamethasone was present for the total 7 h period (Table 3 , line 4). Hence the glucocorticoid effect, once initiated, persists for some hours even after removal of the steroid. Here again, points of difference between glucocorticoid and glucagon stimulation of protein degradation emerge. We have shown previously that protein breakdown is fully stimulated within 1 h after Dexamethasone-l (M) Fig. 3 . Stimulation ofprotein breakdown by 7h exposure to dexamethasone in the presence and absence of cycloheximide Experimental details were as given in Fig. 2 . * Dexamethasone; 0, dexamethasone plus cycloheximide. Values are means+S.E.M. for measurements on twelve dishes in the absence or six dishes in the presence of dexamethasone. Two cell preparations were used. (Hopgood et al., 1980) . Protein degradation, although increased by preincubation of cells with a maximally effective concentration of dexamethasone, was further stimulated by the addition of glucagon (Table 3 , compare line 6 with lines 4 and 5). A similar result was observed with dibutyryl cyclic AMP (Table 3) . These results confirm the evidence provided from Fig. 1 , but in an experimental situation in which the dexamethasone effect is much larger.
Mechanism ofglucocorticoid stimulation
Glucocorticoids have a stabilizing effect on lysosomes, although very high concentrations of steroid are required both in vivo (Weissmann & Thomas, 1964) and in vitro (Weissmann, 1964; Symons et al., 1969) for the effect to be observed. Subsequent investigations have shown that glucocorticoid administration in vivo leads to an increase in the numbers of lysosomes in liver (Wiener et al., 1968) . In addition, glucocorticoids have been found to increase liver lysosomal-enzyme activities in vivo (Bowness et al., 1971; Kyaw & Mellors, 1972) and in various cells in culture (Suzuki et al., 1969; Carubelli & Griffin, 1970; Kyaw & Mellors, 1972) . These results have led to the suggestion that glucocorticoids may stimulate protein degradation via an increase in cellular content of lysosomes (Ballard, 1980; Hopgood & Ballard, 1980) . However, when hepatocyte monolayers were incubated with dexamethasone under the same conditions as those in which protein breakdown was stimulated (Table 3) , there was no change in the total activities of several lysosomal enzymes (Table  4) . These negative results differ from those cited above, but agree with other measurements made after glucocorticoid administration in vivo (Beaufay et al., 1959) or to cells in culture (Lundgren, 1972; Cristofalo & Kabakjian, 1975) . Where increases in lysosomal enzymes have been observed, exposure times have generally been much longer (12h to 30 days) than those where increases in protein breakdown are observed in hepatocyte monolayers.
The stimulation of protein degradation by dexamethasone is slow in onset, persists after removal of the steroid and is completely prevented by cycloheximide. These effects differ from the glucagon response (Hopgood et al., 1980) , and point to an involvement of protein synthesis in glucocorticoid action. Nevertheless, glucocorticoid administration is not accompanied by increases in lysosomal proteolytic enzymes, so perhaps proteins other than lysosomal enzymes are vital to the glucocorticoid effect. One possibility is that dexamethasone may increase the cellular content of neutral proteinases, present in the extra-lysosomal fraction of the cell (Goldberg & St. John, 1976; Etlinger & Goldberg, 1977; DeMartino & Goldberg, 1979; Rose et al., 1979; Ciechanover et al., 1980; Hershko et al., 1980) . However, this explanation is unlikely, because the lysosomotropic agents leupeptin and ammonia prevented the glucocorticoid effect.
There is good evidence that glucagon or dibutyryl cyclic AMP stimulate, and insulin inhibits, protein breakdown in liver via modulation of the rate of autophagocytosis (Deter et al., 1967; Rosa, 1971; Arstila et al., 1972; Shelburne et al., 1973; Neely et al., 1974 Neely et al., , 1977 Grammeltvedt & Berg, 1976; Pfeifer, 1978) . A possible regulatory site for glucocorticoid action may be the supply of precursors for autophagy, e.g. the synthesis of membrane proteins for use in the autophagic process. Such synthetic events would be expected to be sensitive to proteinsynthesis inhibitors and to be relatively slow-acting lInsulinI (M) Fig. 4 . Inhibition of protein degradation by insulin in control and in dexamethasone-preincubated monolayers Experimental details were as given in Fig. 1 , except that some plates were incubated with dexamethasone (10puM) for 3h before the 4h measurement period as described in the Materials and methods section. 0* Control dishes plus or minus insulin; 0, dexamethasone-preincubated dishes plus or minus insulin. Values are means + S.E.M. for measurements on eight dishes in the absence or four dishes in the presence of insulin. Two cell preparations were used. and persistent. In addition, the rapid action of insulin to inhibit the formation of new autophagic vacuoles (Pfeifer, 1979) should prevent glucocorticoid stimulation of protein breakdown when both hormones are added at the same time (Fig. 1) . In contrast, when hepatocyte monolayers were preincubated with dexamethasone before insulin addition, protein breakdown remained stimulated over a subsequent 4 h period (Fig. 4) . This result is to be expected if insulin inhibits the formation of new autophagic vacuoles, but has no effect on subsequent degradative events such as the fusion of autophagic vacuoles with primary lysosomes and proteolysis in secondary lysosomes (autophagosomes). Finally, if maximal stimulation of autophagocytosis and hence protein degradation by glucagon or dibutyryl cyclic AMP were limited by the availability of membranes for autophagy, then the suggested action of glucocorticoids to increase this supply would lead to an additional stimulation of autophagy and of protein breakdown, an effect which is indeed observed (Table 3) . Since glucocorticoid stimulation of protein degradation is effectively blocked by the lysosomotropic agents leupeptin and ammonia, it is apparent that the pathway stimulated by glucocorticoids ultimately involves lysosomal proteolysis.
